This $195,101 Project Grant, awarded by the National Science Foundation's (NSF) Biological Sciences program (CFDA 47.074), will use mathematical modeling to project the healthcare burden associated with COVID-19, influenza, and respiratory syncytial virus (RSV) in the United States during the 2023-2024 respiratory virus season. The research will integrate estimates of population immunity from prior infections, vaccinations, and monoclonal antibody therapy to produce four rounds of projections between September 2023 and February 2024. These projections will guide public health planning efforts and be disseminated through rapid reports, publications, and discussions with the Centers for Disease Control and Prevention (CDC) and other stakeholders. The project will also provide training for two postdoctoral researchers and one Ph.D. student.
Additionally, the University of Georgia Research Foundation, Inc. has been awarded a $195,101 sub-grant to support this work. They will collaborate with the University of Texas at Austin on the data modeling and analysis to inform the respiratory virus burden projections.
Generated 8/13/24, 6:14 AM